GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

Home・Akcijų sąrašas・BioArctic AB

B
BioArctic AB

Uždarymo kaina

284.6 -2.47

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

284.2

Max

285.2

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-896M 179M
Pardavimai	-897M 392M
P/E Sektoriaus vid.	23.701 35.69
Pelnas, tenkantis vienai akcijai	1.09
Pelno marža	45.668
Darbuotojai	119
EBITDA	-893M 188M

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	4.5B 25B
Ankstesnė atidarymo kaina	287.07
Ankstesnė uždarymo kaina	284.6

BioArctic AB Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-09-26 18:25; UTC

Pagrindinės rinkos jėgos

Mirion Technologies Stock Rises on Expanded Notes, Shares Offerings

2025-09-27 07:00; UTC

Uždarbis

This Water Stock Is Dehydrated. What Could Bring It Back. -- Barrons.com

2025-09-27 04:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-09-26 21:56; UTC

Įsigijimai, susijungimai, perėmimai

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

2025-09-26 20:54; UTC

Uždarbis

U.S. TikTok for $14 Billion? Making Sense of the Bargain-Basement Price. -- Barrons.com

2025-09-26 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2025-09-26 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-09-26 20:27; UTC

Įsigijimai, susijungimai, perėmimai

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

2025-09-26 20:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-09-26 19:54; UTC

Rinkos pokalbiai

Canada's Can't-Build Reputation Is Somewhat Earned -- Market Talk

2025-09-26 19:53; UTC

Įsigijimai, susijungimai, perėmimai

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

2025-09-26 19:40; UTC

Uždarbis

The U.S. TikTok Is Apparently Fetching a Bargain-Basement Price. A Few Reasons Why. -- Barrons.com

2025-09-26 19:24; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Mixed As October Expires -- Market Talk

2025-09-26 19:17; UTC

Rinkos pokalbiai

Oil Posts Weekly Gains on Russia-Ukraine Tensions -- Market Talk

2025-09-26 19:15; UTC

Rinkos pokalbiai

AI Deployment Beginning to Weigh on Job Creation, Former Central Banker Says -- Market Talk

2025-09-26 19:03; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-09-26 19:03; UTC

Rinkos pokalbiai

Gold Fuels Stellar Performance in Toronto Stock Market -- Market Talk

2025-09-26 18:50; UTC

Rinkos pokalbiai

Uždarbis

Costco's Executive Membership Gains Seen as Offsetting Slower Renewal Rates -- Market Talk

2025-09-26 18:36; UTC

Rinkos pokalbiai

Silver Closes Out Week With Strong Surge -- Market Talk

2025-09-26 18:02; UTC

Įsigijimai, susijungimai, perėmimai

ING: Continue Working Towards Completing Transaction, Exit From Russian Market >ING

2025-09-26 18:02; UTC

Įsigijimai, susijungimai, perėmimai

ING: Global Development Hasn't Received All Necessary Approvals >ING

2025-09-26 18:02; UTC

Įsigijimai, susijungimai, perėmimai

ING: No Realistic Prospect of Completing Sale of ING Bank (Eurasia) to Global Development in 3Q

2025-09-26 17:54; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises For Fifth Straight Week -- Market Talk

2025-09-26 16:56; UTC

Rinkos pokalbiai

Uždarbis

Costco Increasingly Challenged to Meet Lofty Expectations -- Market Talk

2025-09-26 16:41; UTC

Rinkos pokalbiai

Uždarbis

Costco's Valuation Seen as Too High Amid Slow Down -- Market Talk

2025-09-26 16:26; UTC

Uždarbis

Correction to Sherwin-Williams Extends Losses. What's Ailing the Paint Maker. -- Barrons.com

2025-09-26 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-09-26 16:12; UTC

Rinkos pokalbiai

Nike Stock Seen With Limited Upside -- Market Talk

2025-09-26 15:59; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-09-26 15:59; UTC

Rinkos pokalbiai

Nike Seen Showing Progress in Turnaround -- Market Talk

Akcijų palyginimas

Kainos pokytis

BioArctic AB Prognozė

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.